10 Results

People

  1. Papanicolaou
    Papanicolaou
  2. Perales
    Perales
  3. Su
    Su
  4. Giralt
    Giralt
  5. Fang
    Fang
  6. Huang
    Huang
  7. Jakubowski
    Jakubowski
  8. Kim
    Kim
  9. Maloy
    Maloy
  10. Stern
    Stern

Groups

  1. Department of Medicine (9)
  2. Division of Subspecialty Medicine (8)
  3. Infectious Disease (8)
  4. Bone Marrow Transplant (6)
  5. Center for Hematologic Malignancies (6)
  6. Hematologic Malignancies, Division of (6)
  7. Sloan Kettering Institute Postdocs (5)
  8. Survivorship Research (3)
  9. DigITs Research Group (2)
  10. Biostatistics Service (1)
  1. "preemptive therapy"
Formats
  1. Journal Article (7)
  2. Guidelines (2)
  3. Correspondence (1)
Groups
  1. Department of Medicine (9)
  2. Division of Subspecialty Medicine (8)
  3. Infectious Disease (8)
  4. Bone Marrow Transplant (6)
  5. Center for Hematologic Malignancies (6)
  6. Hematologic Malignancies, Division of (6)

More Groups

People
  1. Genovefa Papanicolaou (8)
  2. Miguel-Angel Perales (5)
  3. Yiqi Su (4)
  4. Sergio Giralt (3)
  5. Anat Stern (2)
  6. Ann Jakubowski (2)

More People

Years
  1. 2024 (4)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (1)
  6. 2016 (1)
Publications
  1. Transplantation and Cellular Therapy (4)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Clinical Infectious Diseases (1)
  4. Cytotherapy (1)
  5. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (7)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Science Ltd. (1)
  4. Oxford University Press (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ASTCT consensus recommendations on testing and treatment of patients with donor-specific anti-HLA antibodies
    Guidelines

    Kongtim, P.; Vittayawacharin, P.; Zou, J.; Srour, S.; Shaffer, B.; Shapiro, R. M.; Varma, A.; McGuirk, J.; Dholaria, B. R.; McCurdy, S. R.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Impact of primary letermovir prophylaxis versus preemptive antiviral therapy for cytomegalovirus on economic and clinical outcomes after hematopoietic cell transplantation
    Journal Article

    Tan, C. A.; Palen, L.; Su, Y.; Li, Y.; Gennarelli, R. L.; Perales, M. A.; Cohen, N.; Papanicolaou, G. A.; Shah, G. L.; Seo, S. K.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Prophylactic radiation therapy for high-risk asymptomatic bone metastases: A new standard of care or need for more data?
    Correspondence

    Chan, A. W.; Simone, C. B.; Van Der Linden, Y.; Hoskin, P.; Detsky, J.; Choi, J. I.; Lee, S. F.; Wong, H. C. Y.; Martin, E. J.; Raman, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Treatment for first cytomegalovirus infection post–hematopoietic cell transplant in the AURORA trial: A multicenter, double-blind, randomized, phase 3 trial comparing maribavir with valganciclovir
    Journal Article

    Papanicolaou, G. A.; Avery, R. K.; Cordonnier, C.; Duarte, R. F.; Haider, S.; Maertens, J.; Peggs, K. S.; Solano, C.; Young, J. A. H.; Fournier, M.; more...
    Clinical Infectious Diseases (2024)

    Fulltext@MSK | Save
  • Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients
    Journal Article

    Camacho-Bydume, C.; Mauguen, A.; Rodriguez-Sanchez, M. I.; Klein, E.; Kernan, N. A.; Prockop, S.; Boelens, J. J.; Papanicolaou, G. A.; Cancio, M.
    Cytotherapy (2022)

    Fulltext@MSK | Save
  • Outcomes of refractory cytomegalovirus infection in the first year after allogeneic hematopoietic cell transplantation
    Journal Article

    Karantoni, E.; Zavras, P. D.; Su, Y.; Fang, J.; Tamari, R.; Cho, C.; Perales, M. A.; Stern, A.; Papanicolaou, G. A.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • American Society for Transplantation and Cellular Therapy series: #3 - Prevention of cytomegalovirus infection and disease after hematopoietic cell transplantation
    Guidelines

    Hakki, M.; Aitken, S. L.; Danziger-Isakov, L.; Michaels, M. G.; Carpenter, P. A.; Chemaly, R. F.; Papanicolaou, G. A.; Boeckh, M.; Marty, F. M.
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Impact of preemptive therapy for cytomegalovirus on hospitalizations and cost after hematopoietic stem cell transplantation
    Journal Article

    Fang, J.; Su, Y.; Zavras, P. D.; Raval, A. D.; Tang, Y.; Perales, M. A.; Giralt, S.; Stern, A.; Papanicolaou, G. A.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Cytomegalovirus infection in allogeneic hematopoietic cell transplantation managed by the preemptive approach: Estimating the impact on healthcare resource utilization and outcomes
    Journal Article

    Huang, Y. T.; Su, Y.; Kim, S. J.; Nichols, P.; Burack, D.; Maloy, M.; Giralt, S.; Perales, M. A.; Jakubowski, A. A.; Papanicolaou, G. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Cytomegalovirus infection after CD34(+)-selected hematopoietic cell transplantation
    Journal Article

    Huang, Y. T.; Neofytos, D.; Foldi, J.; Kim, S. J.; Maloy, M.; Chung, D.; Castro-Malaspina, H.; Giralt, S. A.; Papadopoulos, E.; Perales, M. A.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save